Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CELF2 - Postmortem temporal cortex from Medical Research Council Cognitive Function and Ageing Study (MRC-CFAS) cohort: astrocytes
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CELF2 - Systemic lupus erythematosus patients and yellow fever vaccine-immunized healthy donors: CD16+ monocytes
CELF2 - IFNβ-1a in vivo treatment effect on CIS multiple sclerosis patients: peripheral blood mononuclear cells
CELF2 - Familial hypercholesterolemia and atherosclerosis: T lymphocytes
CELF2 - Progeroid and revertant phenotypes in primary dermal fibroblast cell line GM00038
CELF2 - Transforming growth factor beta effect on CD34+ hematopoietic stem cells
CELF2 - Ovarian normal surface epithelia and ovarian cancer epithelial cells
CELF2 - Huntington's disease: peripheral blood expression profile (HG-U133A)
CELF2 - Model of cerebral aging and Alzheimer's disease: temporal cortex
CELF2 - Insecticides chlorpyrifos and cyfluthrin effect on primary fetal astrocytes
CELF2 - Hematopoietic stem cell and progenitor cell comparison (HG-U133A)
CELF2 - Alzheimer's disease: neurofibrillary tangles
CELF2 - Neonatal brain response to docosahexaenoic acid supplemented formulas
CELF2 - External beam radiation therapy effect on prostate cancer patients: peripheral white blood cells
CELF2 - NCI-60 cancer cell line panel
CELF2 - Recombinant Interferon α effect on natural killer cells in vitro
CELF2 - Systemic lupus erythematosus patients and yellow fever vaccine-immunized healthy donors: CD4 T+ lymphocytes
CELF2 - Tremorogenic chemical harmane effect on astrocytes
CELF2 - Immature dendritic cell response to hypoxia in vitro
CELF2 - Imatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on